These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease]. Kozakiewicz K; Wycisk A Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486 [TBL] [Abstract][Full Text] [Related]
24. HRT vs. heart disease: down but not out. Harv Womens Health Watch; 2001 Sep; 9(1):1-2. PubMed ID: 11572834 [No Abstract] [Full Text] [Related]
25. The controversy over estrogen replacement therapy: an update on clinical trials. Gnatuk CL Curr Womens Health Rep; 2002 Apr; 2(2):89-94. PubMed ID: 12116607 [TBL] [Abstract][Full Text] [Related]
26. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter. Chew S; Ng SC Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777 [TBL] [Abstract][Full Text] [Related]
27. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration. Stefanick ML Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329 [TBL] [Abstract][Full Text] [Related]
29. Is hormone replacement therapy (estrogen plus progestin) effective for the treatment of urinary incontinence in postmenopausal women? Easton BT J Fam Pract; 2001 May; 50(5):470. PubMed ID: 11350716 [No Abstract] [Full Text] [Related]
30. The new conundrum: do estrogens have any cardiovascular benefits? Clarkson TB Int J Fertil Womens Med; 2002; 47(2):61-8. PubMed ID: 11991432 [TBL] [Abstract][Full Text] [Related]
31. Re: "invited commentary: Hormone therapy and risk of coronary heart disease-why renew the focus on the early years of menopause?". Rosenberg L Am J Epidemiol; 2007 Dec; 166(12):1480-1; author reply 1481-2. PubMed ID: 17993654 [No Abstract] [Full Text] [Related]
32. Re: "invited commentary: Hormone therapy and risk of coronary heart disease--why renew the focus on the early years of menopause?". Dören M; Greiser EM Am J Epidemiol; 2007 Dec; 166(12):1479-80; author reply 1481-2. PubMed ID: 17977898 [No Abstract] [Full Text] [Related]
33. Rationale for use of lower estrogen doses for postmenopausal hormone therapy. Ettinger B Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126 [TBL] [Abstract][Full Text] [Related]
34. Venous thrombosis is not increased in younger women on genuine oestrogen postmenopausal hormonal replacement therapy: results from the Danish Osteoporosis Prevention Study (DOPS). Kristensen SR; Abrahamsen B; Madsen JS; Gram J; Rejnmark L; Rud B; Jespersen J Thromb Haemost; 2006 May; 95(5):915-6. PubMed ID: 16676096 [No Abstract] [Full Text] [Related]
35. Guidelines advise against hormone replacement therapy for cardiovascular disease prevention. Rollins G Rep Med Guidel Outcomes Res; 2001 Aug; 12(17):7-9. PubMed ID: 12296365 [No Abstract] [Full Text] [Related]
36. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease. Hodis HN; Mack WJ; Lobo RA Circulation; 2003 Jul; 108(1):e5; author reply e5. PubMed ID: 12847059 [No Abstract] [Full Text] [Related]
38. Polish consensus: procedure in case of estrogen deficiency in women after breast cancer therapy. Milewicz A; Szymański W; Ruzyłło W; Zgliczyński S; Reinfus M; Zieliński J; Debski R; Demissie M; Tworowska U Gynecol Endocrinol; 2002 Oct; 16(5):385-9. PubMed ID: 12587533 [TBL] [Abstract][Full Text] [Related]
39. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety. Crandall C J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124 [TBL] [Abstract][Full Text] [Related]